Estatísticas Básicas
Introdução
Este Rastreador de Interesse de Venda a Descoberto (Short Interest Tracker) fornece uma variedade de dados relacionados à venda a descoberto, obtidos de diversas fontes. Os dados são organizados pela frequência de atualizações, com dados intradiários no topo (disponibilidade de ações para venda a descoberto, taxa de empréstimo para venda a descoberto), dados diários (volume de venda a descoberto, falhas na entrega) no meio, e os dados atualizados mais lentamente (interesse de venda a descoberto) na parte inferior. Observe que o interesse de venda a descoberto é publicado duas vezes por mês, em um calendário definido pela FINRA.
Pontuação de Short Squeeze
A Pontuação de Squeeze de Venda a Descoberto (Short Squeeze Score) é o resultado de um modelo quantitativo sofisticado e multifatorial que identifica as empresas que têm o maior risco de experimentar um squeeze de venda a descoberto. O modelo de pontuação utiliza uma combinação de interesse de venda a descoberto, float, taxas de juros de empréstimos venda a descoberto e outras métricas. O número varia de 0 a 100, com números mais altos indicando um maior risco de um squeeze de venda a descoberto em relação aos seus pares, sendo 50 a média.
Frequência de Atualização: Intradia
Veja nossas Classificações de Squeeze Short para EUA, Canadá, Austrália e Hong Kong
AI+ Ask Fintel’s AI assistant about Alliance Pharma plc.
Select a question to share a public post with an AI-crafted answer.
Funds Disclosing Short Positions - Europe
This section shows European institutions, funds, and major shareholders that have reported short positions in the security.
Upgrade to unlock premium data.
| File Date | Owner | Issuer | ISIN | Total Capitalization Shorted (%) |
|---|---|---|---|---|
| 2025-05-12 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 0.00 |
| 2025-01-10 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 0.65 |
| 2024-11-21 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 0.78 |
| 2024-11-05 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 0.83 |
| 2024-11-01 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 0.72 |
| 2024-10-31 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 0.54 |
| 2024-08-05 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 0.37 |
| 2024-06-19 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 0.61 |
| 2024-05-24 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 0.72 |
| 2024-05-23 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 0.87 |
| 2024-03-12 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 0.98 |
| 2024-02-07 | GLG Partners LP | Alliance Pharma | GB0031030819 | 0.45 |
| 2024-02-06 | GLG Partners LP | Alliance Pharma | GB0031030819 | 0.55 |
| 2024-02-02 | GLG Partners LP | Alliance Pharma | GB0031030819 | 0.67 |
| 2024-02-01 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 1.03 |
| 2024-01-30 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 0.88 |
| 2024-01-29 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 0.96 |
| 2024-01-23 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 1.01 |
| 2024-01-04 | GLG Partners LP | Alliance Pharma | GB0031030819 | 0.70 |
| 2023-12-20 | GLG Partners LP | Alliance Pharma | GB0031030819 | 0.69 |
| 2023-12-14 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 1.18 |
| 2023-11-16 | GLG Partners LP | Alliance Pharma | GB0031030819 | 0.70 |
| 2023-11-07 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 1.25 |
| 2023-11-06 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 1.37 |
| 2023-10-20 | GLG Partners LP | Alliance Pharma | GB0031030819 | 0.64 |
| 2023-10-13 | GLG Partners LP | Alliance Pharma | GB0031030819 | 0.78 |
| 2023-10-10 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 1.49 |
| 2023-09-26 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 1.54 |
| 2023-08-24 | GLG Partners LP | Alliance Pharma | GB0031030819 | 0.87 |
| 2023-08-23 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 1.63 |
| 2023-07-21 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 1.70 |
| 2023-07-19 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 1.63 |
| 2023-07-18 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 1.52 |
| 2023-05-25 | GLG Partners LP | Alliance Pharma | GB0031030819 | 0.70 |
| 2023-05-17 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 1.46 |
| 2023-04-27 | GLG Partners LP | Alliance Pharma | GB0031030819 | 0.66 |
| 2023-04-19 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 1.33 |
| 2023-04-05 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 1.49 |
| 2023-03-29 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 1.53 |
| 2023-03-23 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 1.48 |
| 2023-03-22 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 1.38 |
| 2023-03-17 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 1.12 |
| 2023-03-13 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 1.05 |
| 2023-02-22 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 0.63 |
| 2022-11-24 | JPMorgan Asset Management (UK) Ltd | Alliance Pharma Plc | GB0031030819 | 0.00 |
| 2022-11-23 | JPMorgan Asset Management (UK) Ltd | Alliance Pharma Plc | GB0031030819 | 0.62 |
| 2022-11-10 | JPMorgan Asset Management (UK) Ltd | Alliance Pharma Plc | GB0031030819 | 0.50 |